Novobind Livestock Therapeutics

BiotechnologySeries AVancouver, Canadanovobind.com

Latest round

Series A

Last raised

Jun 2019

Total raised

Undisclosed

Investors

7

About Novobind Livestock Therapeutics

a. NovoBind operates as a biotechnology company that focuses on developing novel biotherapeutic solutions (NBXs) based on single-domain antibodies and complementary to conventional treatments. The company provides single domain antibodies (NBXs) that target pathogens that affect food production and food safety losses and have been materially affected by antibacterial resistance, regulatory ban, and changing human sentiments. These NBXs can be incorporated into feed, feed additives, water, or egg-based applications.

Who invested in Novobind Livestock Therapeutics

7 investors across 1 round

See all investors in Novobind Livestock Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 1, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Novobind Livestock Therapeutics

Who invested in Novobind Livestock Therapeutics?

Novobind Livestock Therapeutics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Novobind Livestock Therapeutics raised?

Novobind Livestock Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Novobind Livestock Therapeutics last raise money?

Novobind Livestock Therapeutics's most recent round on record is a Series A, in Jun 2019.

What does Novobind Livestock Therapeutics do?

Novobind Livestock Therapeutics is a biotechnology company.

Where is Novobind Livestock Therapeutics headquartered?

Novobind Livestock Therapeutics is headquartered in Vancouver, Canada.

Which VCs invest in companies like Novobind Livestock Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Novobind Livestock Therapeutics's stage. Their profiles are linked below.

Raising like Novobind Livestock Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.